CD4 and infection: To facilitate detailed studies of SARS-CoV-2-specific CD4+ T cell responses in B6 mice, we performed a comprehensive screen of potential I-Ab-restricted epitopes in SARS-CoV-2 spike and nucleocapsid proteins, which have been shown to be major immunogenic targets of CD4+ T cells during infection in humans (20).